Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina

NCT01861236 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hormone Dependent Prostate Cancer

Interventions

DRUG: Firmagon® (degarelix)

Sponsor

Ferring Pharmaceuticals